TIAA CREF Investment Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

TIAA CREF Investment Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,612	Closed	-$274K	–	3127
2018 Q1	$274K	Hold	2,612	–	–	﹤0.01%	2922
2017 Q4	$335K	Buy	2,612 +518	+25%	+$63.7K	﹤0.01%	2913
2017 Q3	$242K	Buy	2,094 +86	+4%	+$10.3K	﹤0.01%	3025
2017 Q2	$262K	Buy	+2,008	New	+$271K	﹤0.01%	3059

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

TIAA CREF Investment Management's VBIV Position: Q2 2018 in Review

TIAA CREF Investment Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2018, closing a stake of 2,612 shares — an estimated $274K sold.

TIAA CREF Investment Management first reported a position in VBIV in Q2 2017 and held it in 4 quarters. The position peaked at $335K in Q4 2017. 48 funds tracked by Wall St. Rank hold VBIV as of Q2 2018.

TIAA CREF Investment Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2018 after selling out during the quarter.
TIAA CREF Investment Management sold 2,612 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2018, an estimated $274K.
TIAA CREF Investment Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2017 and held it in 4 quarters.
TIAA CREF Investment Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $335K in Q4 2017.
48 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2018.

Based on TIAA CREF Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.